AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review

The contents of malondialdehyde (MDA) and superoxide dismutase (SOD) in pancreas and liver homogenate were determined with commercial kit (A , A , Nanjing Jiancheng Bioengineering Institute, Nanjing, China). The contents of myeloperoxidase (MPO) were measured with commercial kit (A , Nanjing Jiancheng Bioengineering Institute, Nanjing, China). All measurements were conducted according to the manufacturer’s instructions of the assay kit. In 2008, Narkar et al. reported that, even in sedentary mice, 4 weeks of AICAr treatment alone enhanced running endurance by 44% and induced genes linked to oxidative metabolism in muscle cells.

The animals from groups 3 (saline), 4 (AICAR from study week 1), 5 (AICAR from study week 7), and 6 (Methotrexate/AICAR from study week 7) were maintained on HFD (Table 12). The aim of the study was to evaluate the efficacy of AICAR in the metabolic syndrome aggravated by diabetes mellitus in C57Bl/6 mice fed a high-fat diet combined with circadian rhythm disturbance. SPLScarTM Block (SPL life sciences, Korea) was placed in a 24-well plate, seeded 5 × 104 cells in each side of block, and was allowed to acclimatize overnight. The block was removed, the flash medium replaced, and cells were treated with 5 ng/mL TGF-β1 and different concentrations of AICAR. Cell migration was monitored under a phase-contrast microscope and the migratory distance was calculated.

Moreover, the expression of the markers of osteogenesis—Runx-2, osteopontin, and ALP—was enhanced in AICAR+NAM-, AICAR only-, and NAM only-treated cells compared to the untreated cells (Fig. 4b).
The resulting non-myocyte cells were immediately used for flow cytometry analysis 6 or for tissue culture.
Before the mode of action via AMPK was appreciated, AICAr-mediated protection of myocardium was ascribed only to the effects of adenosine on vasodilation and inhibition of platelet aggregation and neutrophil activation 13,54.
All animals were housed with a 12-h light/dark cycle in a temperature-controlled facility and had free access to water and food.
Moreover, the buildup of endogenous AICAR in the human body has been linked to the development of metabolic disorders.
The absence of changes in SMN protein levels we observed in the spinal cord and skeletal muscle of SMNΔ7 mice after AICAR administration may account for these differences.

After glucose administration to all the mice, hyperglycemia was observed after 30 min (relative to baseline values). Significantly elevated glucose concentrations persisted until the 120th minute in groups 2 (STD + AC), 3 (HFD + vehicle), 5 (HFD + AC 7), and 6 (HFD + AC + MTX), while in groups 1 (STD + vehicle) and 4 (HFD + AC 1) the glucose levels did not differ from the baseline by 120 min. In all the groups, the maximum glucose level was observed by the 30th minute and, from the 60th minute to the 120th minute, the glucose values were significantly reduced relative to this maximum value (Table 7). At the same time, only in groups 1 (STD + vehicle) and 4 (HFD + AC 1) did the values fully recover to the initial level by the 120th minute. So, in all the animals treated with HFD, as well as in the animals treated with AICAR on the background of a standard diet, glucose tolerance was observed.

This shift in cellular metabolism enhances energy production, reduces energy expenditure, and promotes overall cellular health. The anti-cancer potential ofAICAR has spurred extensive research into its use as a therapeutic agent. Studies in mouse models have shown promising results, with AICAR effectively slowing tumor growth and enhancing the efficacy of other cancer treatments. These findings highlight the potential of AICAR as a novel anti-cancer agent and warrant further investigation. AICAR is a naturally occurring molecule that acts as an intermediate in the synthesis of other nucleosides. Despite being an intermediate, it is not found in significant quantities in living organisms.

4. AICAR Exhibits Synergistic Effect with Docetaxel Treatment

Before electrophoresis, β-mercaptoethanol (1 μl/ml) was added to a 12× upper running buffer consisting of 600 mm Tris (base), 900 mm glycine, and 0.6% SDS. Soleus muscle (1.5 μg), tibialis anterior (TA) muscle (1 μg), and extensor digitorum longus (EDL) muscle (1 μg) lysates were prepared as above under “Preparation of Tissue Lysates” (this section of text) and were heated at 95 °C for 5 min in 2× https://www.egegelisimailedanisma.com/strength-and-power-gains-in-training-through/ Laemmli buffer at a final volume of 12 μl. Myosin heavy chain fraction was quantitated from images of scanned gels using the 1D-Multi function of AlphaEase FC software.

Article Access Statistics

Thus, AICAR protects against PALI at least in part through Nrf2-mediated antioxidant effects and inhibition of NLRP3 inflammasome activation. AICAR has been used medically to help with restriction of blood supply to tissues, called ischemia. Interestingly, in the 1980’s it was sometimes used during surgery to help preserve blood flow to the heart. These days, AICAR shows to be promising in diabetes treatment because of its ability to increase metabolic activity of tissues by changing the composition of muscles in the body.

The 3-(4,5 dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide (MTT) assay (Cat# M5655; Sigma-Aldrich) was performed on days 3 and 7 after cell seeding to evaluate the proliferation of MSCs at P10. Briefly, 500 μl of 0.5 mg/ml 3-(4,5 dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide was added to each study group, and the cells were incubated for 4 h at 37 °C. The optical densities (ODs) of the stained solutions were measured with POLARstar Omega Plate Reader Spectrophotometer at 570 nm wavelength 29. Mesenchymal stromal cell (MSC) stemness capacity diminishes over prolonged in vitro culture, which negatively affects their application in regenerative medicine. To slow down the senescence of MSCs, here, we have evaluated the in vitro effects of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an AMPK activator, and nicotinamide (NAM), an activator of sirtuin1 (SIRT1). The ability to control inflammation could reduce the progression of vascular disease, including atherosclerosis.

Cytosol was purified as described.74 Briefly, some 0.15 g of each freshly excised liver tissue or ten 10-cm dishes of cells were homogenized in 800 μl of the homogenization buffer (HB) containing 250 mM sucrose, 3 mM imidazole, pH 7.4. Homogenates were then passed through a 22-G needle attached to a 1-ml syringe for six times, and were then centrifuged at 2000 g for 10 min to yield PNS. PNS samples were then loaded on the top of 11 × 60-mm centrifuge tubes that had been loaded sequentially with 1 ml of 40.6% sucrose (dissolved in HB), 1 ml of 35% sucrose (dissolved in HB), and 1 ml of 25% sucrose (dissolved in HB).

If and where insulin- and contraction-stimulated glucose uptake pathways converge have been topics of considerable interest. Recently, the Akt substrate of 160 kDa (AS160)2 was identified as a mediator of both insulin- and contraction-stimulated glucose uptake and, therefore, a potential nexus for convergent signaling (4, 5). The physical binding of small molecules to targeted proteins yields a complex that can enhance protein stability compared with the free protein when protein is heated at increasing temperatures, as evidenced by the thermal stability assay 82. Our western blot data showed that AICAR incubation in H1975 cells significantly increased protein stability in MUC1-CT than vehicle-treated groups across 37–55 °C (Fig. 2d). Thus, these data have confirmed that MUC1/MUC1-CT is the topmost binding protein to AICAR. For 2D monolayer cell cultures, 3000 cells were plated into each well of a white 96-well plate in three replicates.

The anit-CD3 (2μg/ml, clone 145-2C11, Biolegemd) antibody and anti-CD28 antibody (2μg/ml, clone 37.51, Biolegend) were also used to activate T cells. The designated concentrations (in text and figures) of Compound C (Sigma-Aldrich) and AICAR (Sigma-Aldrich) were used in our experiments. AICAR is a versatile and powerful research tool with wide-ranging applications in metabolic regulation, muscle function, cancer treatment, and cardioprotection.